Glow Therapeutics Inc.
Washington, DC Glow Therapeutics Inc.
- UEI
- X7JMA1XK6FR6
- CAGE
- 04N57
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 819 D St NE Unit 11, Washington, DC 20002, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: the tpmal platform for targeted delivery of photodynamic therapy and chemotherapy to peritoneal metastasis… | National Science Foundation | $305,000 |
Quick answers
What is Glow Therapeutics Inc.'s UEI?
Glow Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is X7JMA1XK6FR6.
What is Glow Therapeutics Inc.'s CAGE code?
Glow Therapeutics Inc.'s CAGE code is 04N57.
What is Glow Therapeutics Inc.'s primary NAICS code?
Glow Therapeutics Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Glow Therapeutics Inc. located?
Glow Therapeutics Inc.'s physical address in SAM.gov is 819 D St NE Unit 11, Washington, DC 20002, USA.
Is Glow Therapeutics Inc. registered in SAM.gov?
Yes. Glow Therapeutics Inc.'s SAM.gov registration is active through June 3, 2027.
What is Glow Therapeutics Inc.'s most recent federal award?
Glow Therapeutics Inc.'s most recent federal grant award is Sbir phase i: the tpmal platform for targeted delivery of photodynamic therapy and chemotherapy to peritoneal metastasis… (2507639), from National Science Foundation, on June 15, 2025.
On GovTribe
See Glow Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors